Journal of Alzheimer s DiseaseNeurosciencePeer-reviewed journal article
Early astrocytic dysfunction is associated to mistuned synapses as well as anxiety and depressive-like behavior in the AppNL-F mouse model of Alzheimers disease
Benjamin PortaliD, Moa Södergren, Teo Parés i Borrell, Romain GiraudiD, Nicole G. MetzendorfiD, Greta HultqvistiD, Per NilssoniD, Maria LindskogiD
Abstract
Alzheimers disease is the most common neurodegenerative disease and constitute 75% of dementia cases worldwide. Unfortunately, efficient and affordable treatments are still lacking for this mental illness, it is therefore urgent to identify new pharmacological targets. Whereas the late phases of the disease are well described, recent evidence suggest synaptic impairments at a pre-amyloid {beta} (A{beta}) plaque stage. Astrocytes are playing a crucial role in the tuning of synaptic transmission and several studies have pointed out severe astrocyte reactivity in Alzheimers disease, especially around A{beta} plaques. Reactive astrocytes show altered physiology and function, suggesting they could have a role in the early pathophysiology of Alzheimers disease. In this study we used the AppNL-F knock-in mouse model of Alzheimers disease which carries two disease-causing mutations inserted in the amyloid precursor protein (App) gene. This strain does not start to develop A{beta} plaques until nine months of age. To better understand early changes in Alzheimers disease, we investigated synaptic function, at both neuronal and astrocytic levels, in six months old AppNL-F mice and correlate the synaptic dysfunction with emotional behavior. Electrophysiological recordings in the hippocampus revealed an overall synaptic mistuning at a pre-plaque stage of the pathology, associated to an intact social memory but a stronger depressive-like behavior. Astrocytes displayed a reactive-like morphology and a higher tonic GABA current compared to control mice. Interestingly, we here show that the synaptic impairments in hippocampal slices are partially corrected by a pre-treatment with the monoamine oxidase B (MAO-B) blocker deprenyl or the fast-acting antidepressant ketamine (5mg/kg). Thus, we propose that reactive astrocytes can induce synaptic mistuning early in Alzheimers disease, before plaques deposition, and that these changes are associated with emotional symptoms. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=144 SRC="FIGDIR/small/540486v2_ufig1.gif" ALT="Figure 1"> View larger version (37K): org.highwire.dtl.DTLVardef@fb19a7org.highwire.dtl.DTLVardef@151454borg.highwire.dtl.DTLVardef@9c7a12org.highwire.dtl.DTLVardef@112633e_HPS_FORMAT_FIGEXP M_FIG GRAPHICAL ABSTRACT C_FIG
- organism: mouse
- assay: electronic health records
- research focus: cell type annotation
- approach: experimental assay
- Citations
- 9
- FWCI
- 2.55
- Field percentile
- top 11%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Early mitochondrial dysfunction proceeds neuroinflammation, synaptic alteration, and autophagy impairment in hippocampus of App knock-in Alzheimer mouse models
Luana Naia, Makoto Shimozawa, … Per Nilsson·bioRxiv·Mar 7, 2023
- Imbalance in the response of pre- and post-synaptic components to amyloidopathy
Terri‐Leigh Stephen, Francesco Tamagnini, … Johanna Jackson·Scientific ReportsPeer-reviewed·Oct 16, 2019
- Astrocyte-neuron interplay is critical for Alzheimer's disease pathogenesis and is rescued by TRPA1 channel blockade
Adrien Paumier, Sylvie Boisseau, … Mireille Albrieux·BrainPeer-reviewed·Jul 22, 2021
- Insoluble Aβ overexpression in an App knock-in mouse model alters microstructure and gamma oscillations in the prefrontal cortex, causing anxiety-related behaviours
Eleftheria Pervolaraki, Stephen P Hall, … James Dachtler·Disease Models & MechanismsPeer-reviewed·Aug 22, 2019
- Differential neural circuit vulnerability to β-amyloid and tau pathologies in novel Alzheimer disease mice
Maria Dolores Capilla-López, Ángel Deprada-Fernandez, … Carlos A. Saura·Molecular PsychiatryPeer-reviewed·Jan 30, 2025
- AETA peptide contributes to Alzheimer's disease signature of synapse dysfunction.
Jade Dunot, Carine Gandin, … Hélène Marie·Acta NeuropathologicaPeer-reviewed·Jun 3, 2026